Verified peer comparison
Merck & Company, Inc. Common Stock (new) vs Bristol-Myers Squibb Company Financial Comparison
Merck & Company, Inc. Common Stock (new) versus Bristol-Myers Squibb Company us…
Direct answer
Merck & Company, Inc. Common Stock (new) and Bristol-Myers Squibb Company are compared on the same basis.
The comparison uses 2025 results reported in USD.
Common metrics include Revenue, Operating income, Net income, Operating cash flow.
Alpha Vantage
Get free Merck & Company, Inc. Common Stock (new) email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Merck & Company, Inc. Common Stock (new) Revenue
- 64,926,000,000 USD
- Bristol-Myers Squibb Company Revenue
- 48,195,000,000 USD
- Merck & Company, Inc. Common Stock (new) Operating income
- 23,486,000,000 USD
- Bristol-Myers Squibb Company Operating income
- 13,724,000,000 USD